Loading organizations...
§ Private Profile · Mountain View
Healthcare technology company providing AI-driven remote patient monitoring, revenue cycle management, and workflow automation for medical practices.
Athelas has raised $282.0M across 5 funding rounds.
Key people at Athelas.
Athelas was founded in 2016 by Deepika Bodapati (Founder) and Tanay Tandon (Founder).
Athelas has raised $282.0M in total across 5 funding rounds.
Based in Mountain View, California, Athelas develops AI-driven healthcare technology, including FDA-cleared remote patient monitoring devices and revenue cycle management software. The company provides an integrated suite of ambient AI clinical documentation and administrative automation tools to streamline workflows for medical practices across North America, Europe, and Asia. Its core hardware offerings include the Athelas One device for at-home immune system tracking and the early detection of conditions such as leukemia. Operating with approximately 1,000 employees, the enterprise raised $336 million across five funding rounds and reached a $1.5 billion valuation in 2022. Athelas is backed by venture capital firms including Sequoia Capital, General Catalyst, and Y Combinator, and it merged with healthcare technology provider Commure in a $6 billion transaction in October 2023. The organization was founded in 2016 by Deepika Bodapati and Tanay Tandon.
Athelas is a healthcare technology company that builds an integrated, AI-powered platform designed to simplify health systems by automating clinical workflows, revenue cycle management, and remote patient monitoring. Its core product suite includes FDA-cleared medical devices like the Athelas One for at-home blood diagnostics, alongside ambient AI tools that assist providers with clinical documentation, coding, billing, and patient engagement. Serving healthcare providers, clinics, and health systems across the U.S., Athelas addresses the challenge of high administrative costs and fragmented care by enabling real-time, remote monitoring and streamlined practice management, which improves patient outcomes and operational efficiency. The company has demonstrated strong growth momentum, underscored by a $200 million funding round in 2025 and a $6 billion acquisition by Commure in 2023, positioning it as a leading innovator in AI-driven healthcare infrastructure[1][3][4][5].
Founded in 2015 by Deepika Bodapati and Tanay Tandon, both with backgrounds in healthcare technology and entrepreneurship, Athelas emerged from the founders’ vision to bring hospital-grade monitoring into patients’ homes and simplify complex healthcare workflows. Early traction came from the successful development of the Athelas One device, enabling early detection of conditions like leukemia and infections remotely. The company evolved from focusing on remote patient monitoring hardware to a broader AI-powered platform that integrates revenue cycle management, electronic health records (EHR), and ambient AI clinical assistants, reflecting a strategic pivot to address the entire healthcare delivery and administrative ecosystem[3][5].
Athelas rides the wave of AI-driven healthcare transformation and the shift toward decentralized, patient-centric care. The timing is critical as healthcare systems face rising administrative costs (over $500 billion annually in the U.S.) and increasing demand for remote monitoring and automation post-pandemic. Market forces such as the push for value-based care, regulatory support for telehealth, and advances in AI and sensor technology favor Athelas’ integrated approach. By streamlining clinical and administrative workflows, Athelas not only improves provider efficiency but also enhances patient outcomes, influencing the broader ecosystem toward more scalable, data-driven healthcare delivery models[1][4][5].
Athelas is poised to expand its footprint beyond remote patient monitoring into comprehensive healthcare infrastructure, leveraging ambient AI to automate complex clinical and financial workflows. Future trends shaping its journey include the growing adoption of AI in healthcare, increased demand for interoperability, and the shift toward outcome-based care models. As it integrates deeper into provider operations and scales its AI capabilities, Athelas could become the industry standard platform for healthcare delivery and administration, driving significant cost savings and quality improvements. Its recent acquisition by Commure and substantial funding rounds underscore a trajectory toward becoming a dominant force in healthcare technology[3][4][5].
Athelas has raised $282.0M across 5 funding rounds. Most recently, it raised $132.0M Other Equity in February 2022.
Key people at Athelas.
Athelas was founded in 2016 by Deepika Bodapati (Founder) and Tanay Tandon (Founder).
Athelas has raised $282.0M in total across 5 funding rounds.
Athelas's investors include Hemant Taneja, Tribe Capital, Greenoaks Capital, Human Capital, Initialized Capital, Sequoia Capital, Y Combinator, Kearny Jackson, Adapt Ventures, Alumni Ventures, Authentic Ventures, BoxGroup.
